Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Aptevo Therapeutics
APVO
$5.16M
| – | – |
0
| – | – |
|
|
BLRX
3502
BioLineRX
BLRX
$11.7M
| $152K | ﹤0.01% |
6,448
+4,742
| +278% | +$141K |
|
|
CARV
3503
DELISTED
Carver Bancorp
CARV
| $152K | ﹤0.01% |
37,100
-14,787
| -28% | -$60.3K |
|
3504
Lifestance Health
LFST
$4.67B
| $152K | ﹤0.01% |
+30,814
| New | +$191K |
|
3505
Pulmonx
LUNG
$92.8M
| $152K | ﹤0.01% |
+18,042
| New | +$172K |
|
|
SPRB
3506
Spruce Biosciences
SPRB
$135M
| $152K | ﹤0.01% |
1,846
-62
| -3% | -$5.19K |
|
3507
DigitalBridge
DBRG
$2.95B
| $151K | ﹤0.01% |
13,825
-189,676
| -93% | -$2.46M |
|
3508
HF Foods Group
HFFG
$97.6M
| $151K | ﹤0.01% |
37,100
-1,600
| -4% | -$6.75K |
|
|
UCL
3509
uCloudlink Group
UCL
$28.6M
| $151K | ﹤0.01% |
45,205
-43,119
| -49% | -$94K |
|
|
VAXX
3510
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $151K | ﹤0.01% |
107,594
-76,041
| -41% | -$128K |
|
3511
Applied Digital
APLD
$8.81B
| $149K | ﹤0.01% |
80,900
+58,500
| +261% | +$115K |
|
|
SACH
3512
Sachem Capital Corp
SACH
$37.6M
| $149K | ﹤0.01% |
45,272
-111,671
| -71% | -$403K |
|
3513
Triple Flag Precious Metals
TFPM
$6.64B
| $148K | ﹤0.01% |
10,700
-100
| -0.9% | -$1.22K |
|
3514
Valens Semiconductor
VLN
$210M
| $148K | ﹤0.01% |
27,600
+12,700
| +85% | +$53.8K |
|
|
STKH
3515
Steakholder Foods
STKH
$1.7M
| $147K | ﹤0.01% |
+120
| New | +$232K |
|
|
ACER
3516
DELISTED
Acer Therapeutics Inc
ACER
| $147K | ﹤0.01% |
58,500
-9,100
| -13% | -$15.6K |
|
3517
Integrated Media Technology
IMTE
$1.84M
| $146K | ﹤0.01% |
21,266
+1,419
| +7% | +$9.54K |
|
3518
Fathom Holdings
FTHM
$23.1M
| $145K | ﹤0.01% |
34,000
+800
| +2% | +$3.78K |
|
3519
United Maritime
USEA
$25.6M
| $145K | ﹤0.01% |
+32,861
| New | +$101K |
|
3520
Yunhong Green CTI Ltd
YHGJ
$8.87M
| $145K | ﹤0.01% |
13,907
-1,680
| -11% | -$13.2K |
|
|
AMPS
3521
DELISTED
Altus Power
AMPS
| $145K | ﹤0.01% |
22,200
-7,700
| -26% | -$62.9K |
|
|
BGXX
3522
DELISTED
Bright Green Corporation Common Stock
BGXX
| $145K | ﹤0.01% |
+309,900
| New | +$180K |
|
|
DDL
3523
Dingdong
DDL
$509M
| $144K | ﹤0.01% |
+33,800
| New | +$133K |
|
3524
Franklin Wireless
FKWL
$28.8M
| $144K | ﹤0.01% |
32,200
-25,396
| -44% | -$88.4K |
|
3525
Similarweb
SMWB
$770M
| $144K | ﹤0.01% |
22,400
+6,400
| +40% | +$36.7K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.